Harrison SJ - Search Results

1

Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.

Dimopoulos MA, Merlini G, Bridoux F, Leung N, Mikhael J, Harrison SJ, Kastritis E, Garderet L, Gozzetti A, van de Donk NWCJ, Weisel KC, Badros AZ, Beksac M, Hillengass J, Mohty M, Ho PJ, Ntanasis-Stathopoulos I, Mateos MV, Richardson P, Blade J, Moreau P, San-Miguel J, Munshi N, Rajkumar SV, Durie BGM, Ludwig H, Terpos E; International Myeloma Working Group. Dimopoulos MA, et al. Among authors: harrison sj. Lancet Oncol. 2023 Jul;24(7):e293-e311. doi: 10.1016/S1470-2045(23)00223-1. Lancet Oncol. 2023. PMID: 37414019 Review.

2

The potential of histone deacetylase inhibitors for the treatment of multiple myeloma.

Prince HM, Bishton M, Harrison S. Prince HM, et al. Leuk Lymphoma. 2008 Mar;49(3):385-7. doi: 10.1080/10428190801950058. Leuk Lymphoma. 2008. PMID: 18297514

3

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma.

Harrison SJ, Quach H, Link E, Seymour JF, Ritchie DS, Ruell S, Dean J, Januszewicz H, Johnstone R, Neeson P, Dickinson M, Nichols J, Prince HM. Harrison SJ, et al. Blood. 2011 Dec 8;118(24):6274-83. doi: 10.1182/blood-2011-03-339879. Epub 2011 Sep 12. Blood. 2011. PMID: 21911830 Free article. Clinical Trial.

4

Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.

Ling SC, Lau EK, Al-Shabeeb A, Nikolic A, Catalano A, Iland H, Horvath N, Ho PJ, Harrison S, Fleming S, Joshua DE, Allen JD. Ling SC, et al. Haematologica. 2012 Jan;97(1):64-72. doi: 10.3324/haematol.2011.043331. Epub 2011 Oct 11. Haematologica. 2012. PMID: 21993678 Free PMC article.

5

Emergence of central nervous system myeloma in the era of novel agents.

Gangatharan SA, Carney DA, Prince HM, Wolf MM, Januszewicz EH, Ritchie DS, Harrison SJ. Gangatharan SA, et al. Among authors: harrison sj. Hematol Oncol. 2012 Dec;30(4):170-4. doi: 10.1002/hon.1021. Epub 2011 Dec 5. Hematol Oncol. 2012. PMID: 22144117 Clinical Trial.

6

Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma.

Doo NW, Thompson PA, Prince HM, Seymour JF, Ritchie D, Stokes K, Burbury K, Wolf M, Joyce T, Harrison SJ. Doo NW, et al. Among authors: harrison sj. Leuk Lymphoma. 2013 Jul;54(7):1465-72. doi: 10.3109/10428194.2012.746682. Epub 2012 Dec 14. Leuk Lymphoma. 2013. PMID: 23121086

7

Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection.

Teh BW, Harrison SJ, Pellegrini M, Thursky KA, Worth LJ, Slavin MA. Teh BW, et al. Among authors: harrison sj. Blood Rev. 2014 Mar;28(2):75-86. doi: 10.1016/j.blre.2014.01.004. Epub 2014 Feb 10. Blood Rev. 2014. PMID: 24582081 Review.

8

The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.

Fleming S, Harrison SJ, Blombery P, Joyce T, Stokes K, Seymour JF, Prince HM, Ritchie D. Fleming S, et al. Among authors: harrison sj. Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):291-6. doi: 10.1016/j.clml.2014.02.001. Epub 2014 Feb 15. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24629850

9

Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Weber N, Mollee P, Augustson B, Brown R, Catley L, Gibson J, Harrison S, Ho PJ, Horvath N, Jaksic W, Joshua D, Quach H, Roberts AW, Spencer A, Szer J, Talaulikar D, To B, Zannettino A, Prince HM. Weber N, et al. Intern Med J. 2015 Apr;45(4):371-82. doi: 10.1111/imj.12566. Intern Med J. 2015. PMID: 25169210 Review.

10

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.

Harrison SJ, Quach H, Link E, Feng H, Dean J, Copeman M, Van De Velde H, Schwarer A, Baker B, Spencer A, Catalano J, Campbell P, Augustson B, Romeril K, Prince HM. Harrison SJ, et al. Am J Hematol. 2015 May;90(5):E86-91. doi: 10.1002/ajh.23967. Epub 2015 Feb 27. Am J Hematol. 2015. PMID: 25651830 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

289 results

Search Page